Skip to main content
. 2015 Mar 6;10:475–487. doi: 10.2147/COPD.S75776

Table 1.

Sociodemographic and clinical characteristics

Characteristics Overall sample day 1a (n=1,663)
Age, mean (SD) 63.9 (8.9)
Sex female, n (%) 778 (46.8)
Race/ethnicity, n (%)
 American Indian/Alaskan native 7 (0.4)
 Asian 6 (0.4)
 Black or African American 95 (5.7)
 Native Hawaiian/Pacific Islander 2 (0.1)
 White 1,550 (93.2)
 Other 3 (0.2)
FEV1, mean (SD), L 1.4 (0.5)
FEV1, % predicted, mean (SD)1 49.0 (14.0)
FVC, mean (SD), L 2.77 (0.85)
SGRQ,b n 1,648
 Total score, mean (SD) 46.5 (18.5)
 Symptoms domain score, mean (SD) 65.1 (21.4)
 Activity domain score, mean (SD) 60.6 (22.3)
 Impacts domain score, mean (SD) 32.7 (19.4)
E-RS total,c mean (SD; n) 9.6 (6.30; 1,658)
GOLD stage, n (%)
 I 4 (0.2)
 II 946 (56.9)
 III 696 (41.9)
 IV 12 (0.7)

Notes:

a

For patients who were missing the NiSCI diary entry on day 1 (day of randomization), data from the closest day before day 1 were used.

b

SGRQ scores range from 0 to 100; higher score=more severe health status.

c

The E-RS total score is an aggregate of three domains identified on the E-RS. Scores range from 0 to 40; higher score=more severe respiratory symptoms.

Abbreviations: SD, standard deviation; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; SGRQ, St George’s Respiratory Questionnaire; E-RS, Exacerbations of Chronic Obstructive Pulmonary Disease Tool-Respiratory Symptoms; GOLD, Global Initiative for Chronic Obstructive Lung Disease; NiSCI, Nighttime Symptoms of COPD Instrument.